Clinical Trial Update: A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in India evaluating the safety and effectiveness of inclisiran sodium for primary hypercholesterolemia or mixed dyslipidemia has been com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Inclisiran sodium (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 4 | Status: COMPLETED